In this interactive breakfast symposium, 3 critical care thought leaders explore the challenge of treating vasodilatory shock. Our panel will review the enormous morbidity and mortality associated with this diagnosis and describe current evidence-based treatment protocols and the real-world challenges associated with adherence to them. They will close by sharing a promising new therapy on the horizon.

Mitchell M. Levy, MD, MCCM

Professor of Medicine, Brown University; Chief, Division of Pulmonary, Critical Care and Sleep Medicine; Medical Director, MICU; Rhode Island Hospital, Providence, Rhode Island

Timothy E. Albertson, MD, MPH, PhD

Professor of Medicine, Pharmacology & Toxicology, Anesthesia & Emergency Medicine; Chair, Department of Internal Medicine, University of California, Davis, Sacramento, California

Ashish K. Khanna, MD

Assistant Professor of Anesthesiology, Cleveland Clinic Lerner College of Medicine; Staff Intensivist, SICU and Center for Critical Care; Staff Anesthesiologist, Department of General Anesthesiology; Vice-Chief for Research Center for Critical Care, Staff Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio

Date

Monday, October 30, 2017

5:30am - 6:00am

Registration, Breakfast, and Seating

6:00am - 6:05am

Welcome and Introduction

Mitchell M. Levy, MD

6:05am - 6:20am

Vasodilatory Shock: Scope of the Human and Economic Burden

Mitchell M. Levy, MD

6:20am - 6:35am

Treating Shock Today: Challenges, Patterns, and Protocols

Timothy E. Albertson, MD, MPH, PhD

6:35am - 6:50am

Evolving Science of Shock Treatment: Which Patient Will Benefit?

Ashish K. Khanna, MD

6:50am - 7:00am

Questions/Concluding Comments

Mitchell M. Levy, MD

Target Audience

This activity is intended for critical care physicians, pulmonologists, and emergency physicians.

Goal Statement

The goal of this program is to raise awareness of the morbidity and mortality associated with vasodilatory shock and explore current and emerging treatment options.

Learning Objectives

Upon completion of this activity, participants will have:
Increased knowledge regarding the

• Human and economic burden of refractory hypotension in patients with vasodilatory shock
• Emerging treatments for refractory hypotension in patients with vasodilatory shock

Greater competence related to

• Identification of patients with clinically refractory hypotension despite adequate fluid resuscitation and catecholamine therapy
• Application of effective shock treatment protocols in the ICU setting

Accreditation Statement

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available:
Maximum Of 1.0 AMA PRA Category 1 Credit(s)™

Medscape, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclaimer

This symposium is not sponsored, endorsed, or accredited by the American College of Chest Physicians.

Sheraton Centre Hotel

Grand Centre Ballroom (Lower Concourse)

123 Queen St W, Toronto, ON M5H 2N2, Canada

Supported by independent educational grant from: